SCA
GH icon

Snowden Capital Advisors’s Guardant Health GH Stock Holding History

Snowden Capital Advisors’s Portfolio GH Stock Details GH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-9,758
Closed -$264K – 1191
2023
Q4 		$264K Sell
9,758
-228
-2% -$5.98K 0.01% 960
2023
Q3 		$296K Sell
9,986
-290
-3% -$10.2K 0.01% 864
2023
Q2 		$368K Buy
+10,276
New +$295K 0.01% 870
2022
Q4 		– Sell
-6,140
Closed -$330K – 1149
2022
Q3 		$330K Buy
+6,140
New +$315K 0.01% 860

Other funds holding GH

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
CCM
Cadian Capital Management New York $1.32B AUM 4.19% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Snowden Capital Advisors's GH Position: Q1 2024 in Review

Snowden Capital Advisors sold out of Guardant Health (GH) in Q1 2024, closing a stake of 9,758 shares — an estimated $264K sold.

Snowden Capital Advisors first reported a position in GH in Q3 2022 and held it in 4 quarters. The position peaked at $368K in Q2 2023. 258 funds tracked by Wall St. Rank hold GH as of Q1 2024.

  • Snowden Capital Advisors reported no remaining Guardant Health position as of Q1 2024 after selling out during the quarter.
  • Snowden Capital Advisors sold 9,758 Guardant Health shares in Q1 2024, an estimated $264K.
  • Snowden Capital Advisors first reported a position in Guardant Health in Q3 2022 and held it in 4 quarters.
  • Snowden Capital Advisors's Guardant Health position peaked at $368K in Q2 2023.
  • 258 funds tracked by Wall St. Rank held Guardant Health as of Q1 2024.

Based on Snowden Capital Advisors's 13F filing for Q1 2024, filed 15 May 2024.